Latest Breaking News On - Company or cognition - Page 3 : comparemela.com

Cognition Therapeutics Releases New Episode Of Conversations Podcast Recorded At CTAD With Quantitative EEG Experts, Drs Willem De Haan And Philip Sc

Cognition Therapeutics Releases New Episode Of Conversations Podcast Recorded At CTAD With Quantitative EEG Experts, Drs Willem De Haan And Philip Sc
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Anthony caggianoPhilip scheltensCognition therapeutics incLife sciencesNational institute of agingCompany or cognitionNational institutes of healthHealth care disclaimerAlzheimer center at amsterdam university medicalSynaptic functionClinical trialsCognition therapeuticSenior researcherAlzheimer centerAmsterdam university medical centerManaging partner

Cognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer s Disease

Cognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer s Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Anthony caggianoDaniel kontoh boatengCasey mcdonaldLisa ricciardiTiberend strategic advisors incCognition therapeutics incCompany or cognitionSecurities exchange commissionNational institute onCognition therapeuticsNational instituteNational institutesInc cognition therapeuticsLooking statements thisPrivate securities litigation reform actTiberend strategic advisors

Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Daniel kontoh boatengCasey mcdonaldLisa ricciardiCognition therapeutics incCompany or cognitionSecurities exchange commissionTiberend strategic advisors incCorporate highlightsOfficer liabilityCognition therapeuticsPrivate securities litigation reform actMonths ended septemberOperations dataBalance sheet dataStrategic advisors

Cognition Therapeutics Presents Complete EEG Findings from SEQUEL Study of CT1812 in Mild-to-Moderate Alzheimer s Disease at CTAD

PURCHASE, N.Y., Oct. 24, 2023 (GLOBE NEWSWIRE) Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) announced that Willem de Haan, M.D., Ph.D., a neurologist and senior researcher at the Amsterdam University Medical Centers’ Alzheimer Center, is presenting complete EEG findings from the Phase 2 SEQUEL study at the Clinical Trials on Alzheimer’s Disease (CTAD) conference. SEQUEL was conducted at the Amsterdam UMC in the Netherlands with Everard (Jort) Vijverberg, M.D.,

Noord hollandCasey mcdonaldJort vijverbergDaniel kontoh boatengCognition therapeutics incCompany or cognitionTiberend strategic advisors incNational institutes of healthNational institute of agingSecurities exchange commissionAmsterdam university medical center alzheimerWillem de haanClinical trialsCognition therapeuticsNational instituteNational institutes

Cognition Therapeutics Announces Participation in Upcoming September Conferences

PURCHASE, N.Y., Aug. 30, 2023 Cognition Therapeutics, Inc. , a clinical-stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular damage.

New yorkUnited statesCasey mcdonaldLisa ricciardiDaniel kontoh boatengCognition therapeutics incHarvard medical schoolCompany or cognitionTiberend strategic advisors incIntercontinental barclay hotelSecurities exchange commissionChief executive officerAnnual global investment conferenceCantor fitzgerald global healthcare conferenceLongwood healthcare leaders fall conferenceLotte new york palace